Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2006-10-03
2006-10-03
Spector, Lorraine (Department: 1646)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S320100, C435S252300, C435S325000, C435S006120, C536S023500, C530S351000
Reexamination Certificate
active
07115398
ABSTRACT:
The present invention is directed to novel polypeptides having sequence identity with IL-17 and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided herein are methods for treating degenerative cartilaginous disorders.
REFERENCES:
patent: 5536637 (1996-07-01), Jacobs
patent: 6562578 (2003-05-01), Gorman et al.
patent: 2003/0092133 (2003-05-01), Ebner et al.
patent: 2003/0186387 (2003-10-01), Ebner, et al.
patent: WO96/29408 (1996-09-01), None
patent: WO 98/49310 (1998-11-01), None
patent: WO 99/03982 (1999-01-01), None
patent: WO 99/61617 (1999-02-01), None
patent: WO99/14240 (1999-03-01), None
patent: WO 99/32632 (1999-07-01), None
patent: WO 99/35267 (1999-07-01), None
patent: WO99/46281 (1999-09-01), None
patent: WO99/60127 (1999-11-01), None
patent: WO 00/20593 (2000-04-01), None
patent: WO00/53752 (2000-09-01), None
patent: WO00/70050 (2000-11-01), None
patent: WO00/73452 (2000-12-01), None
Aarvak et al., “IL-17 Is Produced by Some Proinflammatory Th1/Th0 Cells but not by Th2 Cells”Journal of Immunology162:1246-1251 (1999).
Albanesi et al., “IL-17 Is Produced by Nickel-Specific T Lymphocytes and Regulates ICAM-1 Expression and Chemokine Production in Human Keratinocytes: Synergistic or Antagonist Effects with IFN-γ and TNF-α”Journal of Immunology162:494-502 (1999).
Altschul et al., “Local alignment statistics”Methods in Enzymology266:460-480 (1996).
Antonysamy et al., “Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors”J. Immunol. 162(1) :577-584 (1999).
Antonysamy, M.A. et al., “Evidence for a role of IL-17 in alloimmunity: a novel IL-17 antagonist promotes heart graft survival”Transplant Proc. 31(1-2) :93 (1999).
Arend et al., “Cytokines and Cytokine Inhibitors or Antagonists in Rheumatoid Arthritis”Arthritis Rheum. 33:305-315 (1990).
Ashok R. Amin et al., “The role of nitric oxide in articular cartilage breakdown in osteoarthritis”Current Opinion in Rheumatology10(3) :263-268 (1998).
Attur et al., “Interleukin-17 Up-Regulation of Nitric Oxide Production in Human Osteoarthritis Cartilage”Arthritis and Rheumatism40 (6) :1050-1053 (Jun. 1997).
Awane et al., “NF-κB-Inducing Kinase is a Common Mediator of IL-17-TNF-α, and IL-1β-Induced Chemokine Promoter Activation in Intestinal Epithelial Cells”J. Immunol162:5337-5344 (1999).
Biesinger et al., “Stable growth transformation of human T lymphocytes by Herpesvirus saimiri”Proc. Natl. Acad. Sci. USA89:3116-3119 (Apr. 1992).
BLAST Results A-1—A-1 (Dayhoff).
BLAST Results B-1—B-10 (Dayhoff).
Broxmeyer, H.E., “Is Interleukin 17, An Inducible Cytokine That Stimulates Production of Other Cytokines, Merely a Redundant Player in a Sea of Other Biomolecules?”Journal of Experimental Medicine183:2411-2415 (Jun. 1996).
Chabaud et al., “Enhancing Effect of IL-17 on IL-1-Induced IL-6 and Leukemia Inhibitory Factor Production by Rheumatoid Arthritis Synoviocytes and Its Regulation by Th2 Cytokines”Journal of Immunology161:409-414 (1998).
Chabaud et al., “Human Interleukin-17: A T Cell-Derived Proinflammatory Cytokine Produced by the Rheumatoid Synovium”Arthrtis&Rheumatism42 (5) :963-970 (1999).
Farndale et al., “Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue”Biochem. Biophys. Acta883:173-177 (1986).
Fleckenstein and Desrosiers, “Herpesvirus saimiri and herpesvirus ateles”In the Herpesvirus, I.B. Roizman, ed., NY:Plenum Publishing Press pp. 253-332 (1982).
Fossiez et al., “Interleukin-17”Int. Rev. Immunol.16(5-6) :541-551 (1998).
Fossiez et al., “T Cell Interleukin-17 Induces Stromal Cells to Produce Proinflammatory and Hematopoietic Cytokines”Journal of Experimental Medicine183 (6) :2593-2603 (Jun. 1996).
Gordon et al., “Molecular immunobiology of macrophages: recent progress”Current Opinion in Immunology7:24-33 (1995).
Hillier et al., “af37c02.sl Soares total fetus Nb2HF8 9wHomo sapienscDNA clone 1033826 3′” (Accession No. AA780147) (Feb. 6, 1998).
Hillier et al., “zf01f09.sl Soares fetal heart NbHH19WHomo sapienscDNA clone 375689 3′” (Accession No. AA033733) (Feb. 4, 1997).
Jovanovic et al., “IL-17 Stimulates the Production and Expression of Proinflammatory Cytokines, IL-β and TNF-α, by Human Macrophages”J. Immunol160:3513-3521 (1998).
Jovanovic et al., “Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages”Arthritis and Rheumatism43 (5) :1134-1144 (2000).
Kennedy et al., “Mouse IL-17: A Cytokine Preferentially Expressed by αβTCR+CD4-CD8- T Cells”Journal of Interferon and Cytokine Research16 (8) :611-617 (1996).
Kingsley et al., “Joint destruction in rheumatoid arthritis: biological bases”Clin. Exp. Rheumatol. 15:S3-S14 (1997).
Klein et al., “Selection for Genes Encoding Secreted Proteins and Receptors”Proc. Natl. Acad. Sci. USA93 (14) :7108-7113 (1996).
Kong et al., “Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand”Nature402(6759) :304-309 (1999).
Kotake et al., “IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis”Journal of Clinical Investigation103 (9) :1345-1352 (1999).
Lennon et al., “The I.M.A.G.E. Consortium: An Integrated Molecular Analysis of Genomes and Their Expression”Genomics(Article #0177) 33:151-152 (1996).
Li et al., “Cloning and characterization of the IL-17B and IL-17C two new members of the IL-17 cytokine family”Proc. Natl. Acad. Sci. USA97(2) :773-778 (2000).
Lotz et al., “IL-17 Promotes Cartilage Degradation”Cytokines(ACR Abstract Session 10, Oct. 19, 1996, abstract #559) pp. S120 (1996).
Luckow et al., “Trends in the Development of Baculovirus Expression Vectors”Bio/Technology6:47-55 (1988).
March et al., “Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs”Nature315:641-647 (Jun. 20, 1985).
Marra et al., “The WashU-HHMIMouse EST project, Locus AA763404, Jan. 27, 1998, Accessed Dec. 13, 2000”.
Martel-Pelletier et al., “Major Signaling Pathways Involved in the IL-17 Induced Nitric Oxide (NO) Production in Human Osteoarthritic Chondrocytes”Orthopaedic Research Society(45th Annual Meeting, Feb. 1-4, 1999, pt 2) 24:595 (1999).
Matusevicius et al., “Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis”Multiple Sclerosis5:101-104 (1999).
Rouvier et al., “CTLA-8, Cloned from an Activated T Cell, Bearing AU-Rich Messenger RNA Instability Sequences, and Homologous to a Herpesvirus Saimiri Gene”Journal of Immunology150 (12) :5445-5456 (Jun. 15, 1993).
Schwarzenberger et al., “IL-17 Stimulates Granulopoiesis in Mice: Use of an Alternate, Novel Gene Therapy-Derived Method for In Vivo Evaluation of Cytokines”Journal of Immunology161:6383-6389 (1998).
Seow, H. F., “Pathogen interactions with cytokines and host defence: an overview”Vet Immunol. Immunopathol. 63 (1-2) :139-148 (1998).
Shalom-Barak et al., “Interleukin-17-induced Gene Expression in Articular Chondrocytes is Associated with Activation of Mitogen-activated Protein Kinases and NF-&
Chen Jian
Filvaroff Ellen
Goddard Audrey
Gurney Austin
Li Hanzhong
Genentch, Inc.
Jiang Dong
Sidley Austin LLP
Spector Lorraine
LandOfFree
IL-17 homologous polypeptides and therapeutic uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with IL-17 homologous polypeptides and therapeutic uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and IL-17 homologous polypeptides and therapeutic uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3691174